Search Results

Filter
  • 1-10 of  155 results for ""Drug Eruptions""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Evaluation of anticancer therapy-related dermatologic adverse events: Insights from Food and Drug Administration's Adverse Event Reporting System dataset.

  • Authors : Salah S; La Roche-Posay Laboratoire Dermatologique, Levallois Perret, France. Electronic address: .; Kerob D

Subjects: Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/statistics & numerical data ; United States Food and Drug Administration* ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/adverse effects

  • Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Nov; Vol. 91 (5), pp. 863-871. Date of Electronic Publication: 2024 Jul 20.Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium:

Record details

×
Editorial & Opinion

Drug patch testing for severe cutaneous adverse reactions: Not in the United States?

  • Authors : Whitley L; Los Alamos Medical Care Clinic Ltd, Los Alamos, New Mexico; Department of Clinical Medicine, Burrell College of Osteopathic Medicine, Las Cruces, New Mexico.

Subjects: Skin* ; Drug Eruptions*; Humans

  • Source: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology [Ann Allergy Asthma Immunol] 2023 May; Vol. 130 (5), pp. 538-539.Publisher: American College of Allergy, Asthma, and Immunology Country of Publication: United States NLM ID: 9503580 Publication

Record details

×
Academic Journal

Epidemiology and risk factors for the development of cutaneous toxicities in patients treated with immune-checkpoint inhibitors: A United States population-level analysis.

  • Authors : Wongvibulsin S; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Subjects: Drug Eruptions*/Drug Eruptions*/Drug Eruptions*/drug therapy ; Drug Eruptions*/Drug Eruptions*/Drug Eruptions*/epidemiology ; Drug Eruptions*/Drug Eruptions*/Drug Eruptions*/etiology

  • Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2022 Mar; Vol. 86 (3), pp. 563-572. Date of Electronic Publication: 2021 Apr 02.Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Cutaneous reactions in children treated with MEK inhibitors, BRAF inhibitors, or combination therapy: A multicenter study.

  • Authors : Boull CL; Division of Pediatric Dermatology, University of Minnesota, Minneapolis, Minnesota.; Gardeen S

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*adverse effects ; Drug Eruptions/Drug Eruptions/Drug Eruptions/*epidemiology ; Neoplasms/Neoplasms/Neoplasms/*drug therapy

  • Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2021 Jun; Vol. 84 (6), pp. 1554-1561. Date of Electronic Publication: 2020 Jul 17.Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Disproportionality analysis of bullous pemphigoid adverse events with PD-1 inhibitors in the FDA adverse event reporting system.

  • Authors : Aggarwal P; a College of Medicine , University of Cincinnati Medical Center , Cincinnati , OH , USA.

Subjects: Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/*adverse effects ; Drug Eruptions/Drug Eruptions/Drug Eruptions/*etiology ; Nivolumab/Nivolumab/Nivolumab/*adverse effects

  • Source: Expert opinion on drug safety [Expert Opin Drug Saf] 2019 Jul; Vol. 18 (7), pp. 623-633. Date of Electronic Publication: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101163027 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Racial/ethnic variation and risk factors for allopurinol-associated severe cutaneous adverse reactions: a cohort study.

  • Authors : Keller SF; Division of Rheumatology, Allergy and Immunology, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA.; Lu N

Subjects: Allopurinol/Allopurinol/Allopurinol/*adverse effects ; Drug Eruptions/Drug Eruptions/Drug Eruptions/*ethnology ; Gout Suppressants/Gout Suppressants/Gout Suppressants/*adverse effects

  • Source: Annals of the rheumatic diseases [Ann Rheum Dis] 2018 Aug; Vol. 77 (8), pp. 1187-1193. Date of Electronic Publication: 2018 Apr 13.Publisher: BMJ Country of Publication: England NLM ID: 0372355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2060

Record details

×
Editorial & Opinion

Retrospective analysis of dermatologic adverse events associated with hydroxychloroquine reported to the US Food and Drug Administration.

  • Authors : Lipner SR; Department of Dermatology, Weill Cornell Medicine, New York, New York. Electronic address: .; Wang Y

Subjects: Adverse Drug Reaction Reporting Systems*; Drug Eruptions/Drug Eruptions/Drug Eruptions/*etiology ; Hydroxychloroquine/Hydroxychloroquine/Hydroxychloroquine/*adverse effects

  • Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2020 Nov; Vol. 83 (5), pp. 1527-1529. Date of Electronic Publication: 2020 Jul 08.Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium:

Record details

×
Editorial & Opinion

Adverse event monitoring in patients on oral systemic medications for inflammatory skin disease.

  • Authors : Singh P; Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.; Silverberg JI

Subjects: Dermatitis, Atopic/Dermatitis, Atopic/Dermatitis, Atopic/*drug therapy ; Drug Eruptions/Drug Eruptions/Drug Eruptions/*etiology ; Psoriasis/Psoriasis/Psoriasis/*drug therapy

  • Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2020 Jun; Vol. 82 (6), pp. 1537-1539. Date of Electronic Publication: 2020 Feb 20.Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Human Cumulative Irritation Tests of Common Preservatives Used in Personal Care Products: A Retrospective Analysis of Over 45 000 Subjects.

  • Authors : Walters RM; JOHNSON & JOHNSON Consumer Companies, Inc., Skillman, New Jersey 08558; .

Subjects: Cosmetics/Cosmetics/Cosmetics/*toxicity ; Drug Eruptions/Drug Eruptions/Drug Eruptions/*etiology ; Skin/Skin/Skin/*drug effects

  • Source: Toxicological sciences : an official journal of the Society of Toxicology [Toxicol Sci] 2015 Nov; Vol. 148 (1), pp. 101-7. Date of Electronic Publication: 2015 Jul 23.Publisher: Oxford University Press Country of Publication: United States NLM ID: 9805461 Publication Model: Print-Electronic

Record details

×
Academic Journal

Rash and elevated creatine kinase in a deployed soldier.

  • Authors : Schmidt TW; Department of Rheumatology, Brooke Army Medical Center, 3551 Roger Brooke Drive, Fort Sam Houston, TX 78234-6272.; Garfinkle M

Subjects: Military Personnel*; Anti-Infective Agents/Anti-Infective Agents/Anti-Infective Agents/*adverse effects ; Dermatomyositis/Dermatomyositis/Dermatomyositis/*diagnosis

  • Source: Military medicine [Mil Med] 2014 Feb; Vol. 179 (2), pp. e245-8.Publisher: Oxford University Press Country of Publication: England NLM ID: 2984771R Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  155 results for ""Drug Eruptions""